Sunshine Nuohe announced that the related company, Sichuan Shengpu Pharmaceutical Technology Center (limited partnership), which is actually controlled by Mr. Li Yuanbo, the company's senior manager, plans to purchase the company's A-shares within 6 months from April 1, 2024 through methods permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding, continuous bidding, and bulk trading, etc.). The total purchase amount is not less than RMB 28 million and no more than RMB 32 million.
阳光诺和：晟普医药拟购买公司股份2800万元-3200万元
Sunshine Novo: Shengpu Pharmaceutical plans to purchase shares of the company for 28 million yuan to 32 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.